Description
Tirzepatide is a dual incretin research peptide studied across GIP and GLP-1 receptor pathways. Researchers compare it with GLP-1-only compounds like Semaglutide to better understand how adding GIP pathway activity changes metabolic-signalling models.
Molecular Profile
Molecular Weight: Refer to batch COA
Purity: Per batch COA
Format: Lyophilized white powder
Storage: -20°C, desiccated
Reconstitution: Sterile bacteriostatic water
Research Context
Tirzepatide is studied in metabolic signalling research involving GIP and GLP-1 receptor pathways. Research teams use dual incretin agonists to evaluate receptor-specific contributions to glucose metabolism, appetite-related signalling, adipose tissue biology, and downstream endocrine pathway regulation.
Quality Assurance
Each batch is independently tested for purity, identity, and quality before release. A Certificate of Analysis is available for every lot. All compounds are produced under strict quality control conditions and shipped under appropriate handling protocols from within Canada.
